ProQR to Present at the Chardan Genetic Medicines Conference
02 oct. 2018 07h00 HE
|
ProQR Therapeutics N.V.
LEIDEN, the Netherlands, Oct. 02, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the...
ProQR to Present at the JMP Life Sciences Conference
14 juin 2018 07h00 HE
|
ProQR Therapeutics N.V.
LEIDEN, the Netherlands, June 14, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the...
ProQR to Present at the Chardan Inaugural Gene Therapy Conference
06 oct. 2017 07h00 HE
|
ProQR Therapeutics N.V.
LEIDEN, the Netherlands, Oct. 06, 2017 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the...
ProQR Presents in vivo Proof of Concept Data for the Axiomer® RNA Editing Platform Technology
21 sept. 2017 07h05 HE
|
ProQR Therapeutics N.V.
Key updates ProQR presents in vivo data in a relevant disease model, establishing proof of concept for its novel and proprietary Axiomer® RNA editing platform technology.Axiomer® technology Editing...
ProQR to Present at the Deutsche Bank Health Care Conference
20 avr. 2017 07h00 HE
|
ProQR Therapeutics
LEIDEN, the Netherlands, April 20, 2017 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR) today announced that Gerard Platenburg, Chief Innovation Officer, will present at the 42nd Annual...